Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079024 · ClinicalTrials.gov registry record · NA
Minnesota Community-Based Cognitive Training in Early Psychosis
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03079024: Completed NA study, sponsored by University of Minnesota.
NCT03079024 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03079024, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cognitive training exercises can improve cognitive functioning in young patients with recent-onset psychosis who are being treated in community mental health settings using the NAVIGATE model. The investigators will examine the effects of web-based cognitive training exercises delivered on iPads. Participants will be randomized to one of three conditions, and will be assessed at Baseline, Post-Intervention, and 6 Month Follow Up on measures of clinical, neurocognitive, and functional status.
Primary Outcome
A composite T-score of: 1. Symbol Coding from the Brief Assessment of Cognition in Schizophrenia (BACS): Symbol Coding. Timed paper-and-pencil test in which respondent uses a key to write digits that correspond to nonsense symbols. 2. Category Fluency: Animal Naming: Oral test in which respondent names as many animals as she/he can in 1 minute. 3. Trail Making Test: Part A: Timed paper-and-pencil test in which respondent draws a line to connect consecutively numbered circles placed irregularly
Interventions
- DEVICE Targeted Cognitive Training
- DEVICE General Cognitive Exercises
- OTHER Coordinated Specialty Care for First Episode Psychosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2022-03-26 |
| Phase | NA |
What the finished NCT03079024 record still lists
NCT03079024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Targeted Cognitive Training is the first listed.
NCT03079024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03079024 about?
NCT03079024 is a clinical study titled "Minnesota Community-Based Cognitive Training in Early Psychosis". The purpose of this study is to determine whether cognitive training exercises can improve cognitive functioning in young patients with recent-onset psychosis who are being treated in community mental health settings using the NAVIGATE model. The investigators will examine the effects of web-based c...
What is the current status of trial NCT03079024?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-05-19. Estimated completion is 2022-03-26.
What interventions are being tested in trial NCT03079024?
The interventions under investigation include: Targeted Cognitive Training (DEVICE), General Cognitive Exercises (DEVICE), Coordinated Specialty Care for First Episode Psychosis (OTHER).
Who is sponsoring clinical trial NCT03079024?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03079024's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI